Featured Research

from universities, journals, and other organizations

Researchers Pave The Way To Protein Therapy In Humans

Date:
September 9, 1999
Source:
Washington University School Of Medicine
Summary:
For decades, pharmaceutical companies have struggled to overcome the molecular equivalent of the Great Wall of China: the outer membrane of cells, which prevents all but the tiniest of proteins from entering. Now researchers have slipped a protein that's more than 200 times larger than the average drug into the cells of living mice and shown that the protein functions.

St. Louis, Sept. 3, 1999 — For decades, pharmaceutical companies have struggled to overcome the molecular equivalent of the Great Wall of China: the outer membrane of cells, which prevents all but the tiniest of proteins from entering. Now researchers have slipped a protein that's more than 200 times larger than the average drug into the cells of living mice and shown that the protein functions.

Related Articles


"For the very first time, we've introduced a large, biologically active protein into every cell of the body — including cells in the brain that are normally protected by the blood-brain barrier," says Steven F. Dowdy, Ph.D., who led the research team at Washington University School of Medicine in St. Louis. The group published its results in today's issue of Science.

Dowdy is an assistant investigator of the Howard Hughes Medical Institute and an assistant professor of pathology and medicine. Steven R. Schwarze, Ph.D., a postdoctoral fellow in his laboratory, was lead author of the paper.

Getting full-sized, therapeutic proteins into cells would be advantageous because smaller drugs tend to interact with unintended targets. Larger proteins fit only onto the molecules for which they were designed, so they could be given in substantially lower doses, resulting in fewer side effects.

Dowdy led a previous research team that used test-tube experiments to smuggle an enzyme into HIV-infected cells. The results, reported in Nature Medicine last December and January focused on a human enzyme that makes cells self-destruct. The enzyme was modified to include a string of 11 amino acids that served as a passport for crossing a cell's outer membrane. But the researchers needed to prove that large proteins could slip into cells in model animals before considering human applications.

In the Science study, Dowdy and fellow investigators first attached a molecular passport known as a protein transduction domain (PTD) to a compound whose uptake by cells could be monitored. The compound was a dye called fluorescein, which turns green when exposed to fluorescent lighting. It normally doesn't enter cells because of its size — 2,000 daltons compared with the 500 dalton limit placed on most drugs.The researchers injected mice with this combined PTD-fluorescein protein and isolated cells from the animals' blood and spleen. All the cells fluoresced green when checked 20 minutes after the injection. Cells in muscle and brain tissue also had soaked up the combined protein. "It was very encouraging to discover that we could get a mouse with an entirely green brain," Dowdy says, noting that the blood-brain barrier, a layer of cells lining the brain's blood vessels, normally prevents most proteins from entering.

Dowdy and colleagues then linked a bacterial enzyme to the PTD and fluorescein. Their fluorescent analysis revealed that the 120,000 dalton enzyme, beta-galactosidase, entered all the cell types tested.

Beta-galactosidase was chosen because its activity could reveal whether an enzyme could continue to function after it had been transported into cells by the PTD. Cells take up proteins better if they are at least partially unfolded, as was true for the enzyme.

Dowdy's team tested whether beta-galactosidase trapped inside cells of injected mice converted the enzyme's clear chemical target into a blue dye. A vibrant blue image of the kidney of the first mouse tissue they evaluated is pinned on a bulletin board above Dowdy's desk. "Once we got this first result, we realized that the protein would be biologically active in the rest of the body," Dowdy says.

The liver, lung, and other tissues of the injected mice also turned blue when exposed to the enzyme's target. The animals' entire brains also stained blue within four hours of injection, indicating that a lot of the bacterial enzyme had refolded there by then. Importantly, the PTD didn't work its magic in the brain by destroying the blood-brain barrier. And the animals had no visible behavioral changes or other differences compared with untreated mice.

Dowdy has since tested modified versions of the PTD that should allow proteins to enter brain cells and other cells even more rapidly. And he is using his new technology to determine whether a malfunctioning protein helps jump-start cancer.

He notes that the laboratory's protein-targeting technology also may enable companies to create drugs that act only in disease-related cells, opening up a completely novel avenue of therapeutic approaches. "We can now do things in normal cells of mice that you could never even dream of doing with any reliability a year ago," Dowdy says.


Story Source:

The above story is based on materials provided by Washington University School Of Medicine. Note: Materials may be edited for content and length.


Cite This Page:

Washington University School Of Medicine. "Researchers Pave The Way To Protein Therapy In Humans." ScienceDaily. ScienceDaily, 9 September 1999. <www.sciencedaily.com/releases/1999/09/990909080620.htm>.
Washington University School Of Medicine. (1999, September 9). Researchers Pave The Way To Protein Therapy In Humans. ScienceDaily. Retrieved March 31, 2015 from www.sciencedaily.com/releases/1999/09/990909080620.htm
Washington University School Of Medicine. "Researchers Pave The Way To Protein Therapy In Humans." ScienceDaily. www.sciencedaily.com/releases/1999/09/990909080620.htm (accessed March 31, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, March 31, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Solitair Device Aims to Takes Guesswork out of Sun Safety

Solitair Device Aims to Takes Guesswork out of Sun Safety

Reuters - Innovations Video Online (Mar. 31, 2015) — The Solitair device aims to take the confusion out of how much sunlight we should expose our skin to. Small enough to be worn as a tie or hair clip, it monitors the user&apos;s sun exposure by taking into account their skin pigment, location and schedule. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Soda, Salt and Sugar: The Next Generation of Taxes

Soda, Salt and Sugar: The Next Generation of Taxes

Washington Post (Mar. 30, 2015) — Denisa Livingston, a health advocate for the Dinι Community Advocacy Alliance, and the Post&apos;s Abby Phillip discuss efforts around the country to make unhealthy food choices hurt your wallet as much as your waistline. Video provided by Washington Post
Powered by NewsLook.com
UnitedHealth Buys Catamaran

UnitedHealth Buys Catamaran

Reuters - Business Video Online (Mar. 30, 2015) — The $12.8 billion merger will combine the U.S.&apos; third and fourth largest pharmacy benefit managers. Analysts say smaller PBMs could also merge. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
S. Leone in New Anti-Ebola Lockdown

S. Leone in New Anti-Ebola Lockdown

AFP (Mar. 28, 2015) — Sierra Leone imposed a three-day nationwide lockdown Friday for the second time in six months in a bid to prevent a resurgence of the deadly Ebola virus. Duration: 01:17 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins